HYPERION DEFI, INC. Gain (Loss) on Extinguishment of Debt
HYPERION DEFI, INC. (HYPD) reported Gain (Loss) on Extinguishment of Debt of $89.62 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2025-08-13
- HYPERION DEFI, INC. gain (loss) on extinguishment of debt for the quarter ending 2025-06-30 was $0.00.
- HYPERION DEFI, INC. gain (loss) on extinguishment of debt for the quarter ending 2025-03-31 was $89.62K.
- HYPERION DEFI, INC. gain (loss) on extinguishment of debt for the quarter ending 2022-12-31 was $0.00.
- HYPERION DEFI, INC. gain (loss) on extinguishment of debt for the quarter ending 2021-12-31 was $0.00.
- HYPERION DEFI, INC. gain (loss) on extinguishment of debt for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- HYPERION DEFI, INC. gain (loss) on extinguishment of debt for fiscal 2021 was $463.35K.
- HYPERION DEFI, INC. gain (loss) on extinguishment of debt for fiscal 2020 was $0.00.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $89.62K 10-Q · filed 2025-08-13 | ||
| 2025-03-31 | $89.62K 10-Q · filed 2025-05-19 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 10-K · filed 2023-03-31 | ||
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $463.35K derived: sum of 2 quarters · filed 2023-03-31 | $463.35K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $463.35K 10-Q · filed 2022-11-14 | $463.35K 10-Q · filed 2022-11-14 | ||
| 2020-12-31 | $0.00 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |